In April, the Information Regulator published amendments to the Protection of Personal Information Act (POPIA) Regulations, significantly enhancing privacy protections for South Africans. These changes simplify the processes for objecting to data processing, requesting corrections or deletions, and obtaining consent for direct marketing. They also introduce new responsibilities for information officers and allow for administrative fines to be paid in installments.

Following the public consultation in 2024, the Personal Data Protection Commissioner has now issued the Personal Data Protection Guideline on Cross Border Personal Data Transfer (Guideline).
The Guideline provides guidance on the operationalization of section 129 of the Personal Data Protection Act 2010 and sets out specific responsibilities of data controllers when transferring personal data to any place outside Malaysia.

The General Authority for Competition in Saudi Arabia has recently published its quarterly report on economic concentration applications for Q1 2025. This alert summarizes the key highlights of the report published by the authority, with particular focus on the issuance of the first conditional approvals of the year.

On 6 May 2025, the US Food and Drug Administration (FDA) announced that it will expand the use of unannounced inspections at foreign manufacturing facilities that produce foods, essential medicines, and other medical products intended for US consumers and patients. The announcement came one day after the White House issued an Executive Order instructing FDA to provide regulatory relief to promote domestic production of critical medicines and improve FDA’s risk-based inspection regime to enhance routine inspections of foreign facilities. The expansion will build upon FDA’s existing Foreign Unannounced Inspection Pilot Program in India and China, with the aim of ensuring that foreign facilities will receive the same level of regulatory oversight and scrutiny as domestic facilities.